Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ENROLLING BY INVITATION
NCT02751060
Evaluation of Plasma Non-coding RNAs as Biomarkers in Coronary Heart Disease
Sponsor: Tongji Hospital
View on ClinicalTrials.gov
Summary
The purpose of this study is to determine whether the expression level of miR-320a are effective as biomarker in evaluating the diagnosis, prognosis and treatment effects of coronary heart disease.
Official title: Evaluation of Plasma Non-coding RNAs (miRNA-320a) as Biomarkers of Diagnosis, Prognosis and Treatment Effects in Coronary Heart Disease
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
4000
Start Date
2016-04
Completion Date
2026-12
Last Updated
2024-04-10
Healthy Volunteers
No
Conditions
Interventions
OTHER
No intervention
Locations (1)
Tongji Hospital
Wuhan, Hubei, China